Table 1.
Overview of the visits and measurements
| Follow-up | ||||
| Visit Number | 1 | 2 | 3–4–5... | Final visit |
| Month | 0 | 3 | 6-month intervals | |
| Inclusion/Exclusion criteria | x | |||
| Informed Consent | x | |||
| Medical history | x | |||
| Concomitant Medication | x | x | x | x |
| Weight | x | x | x | |
| Height | x | |||
| Waist circumference | x | x | x | |
| Blood pressure/Heart rate | x | x | x | |
| HbA1c | x | x | x | |
| AST, ALT | x | x | x | |
| Creatinine | x | x | x | |
| Microlbuminuria | x | x | x | |
| Albumin/creatinine ratio | x | x | x | |
| Total cholesterol, HDL cholesterol, Triglycerides | x | x | x | x |
| Adverse events | x | x | x | |
| Compliance | x | x | x | |
| End-point verification | x | x | x | |